Campus Review The latest in higher education news
Oxford University researchers have begun the first trials of an experimental preventive Ebola vaccine regimen developed by Janssen Pharmaceutical Companies.
Please login below to view content or subscribe now.
Membership Login
Get the news delivered straight to your inbox
Receive the top stories in our weekly newsletter Sign up now